Overview

Trial of Indomethacin in Chronic Pancreatitis

Status:
Recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

The researchers are trying to find a way to slow down the progression of chronic pancreatitis (CP) and investigate the possibility of the long term treatment of this disease.

Phase:

Phase 2

Details

Lead Sponsor:

Mayo Clinic

Collaborator:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Treatments:

Indomethacin